AVAI BIO, INC. Research and Development Expense
AVAI BIO, INC. (AVAI) reported Research and Development Expense of $15.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-14
- AVAI BIO, INC. research and development expense for the quarter ending 2026-03-31 was -$8.80K.
- AVAI BIO, INC. research and development expense for the quarter ending 2025-12-31 was $0.00.
- AVAI BIO, INC. research and development expense for the quarter ending 2025-09-30 was $23.80K.
- AVAI BIO, INC. research and development expense for the quarter ending 2025-06-30 was $0.00.
- AVAI BIO, INC. research and development expense for fiscal 2026 was $15.00K.
- AVAI BIO, INC. research and development expense for fiscal 2020 was $27.04K.
- AVAI BIO, INC. research and development expense for fiscal 2019 was $0.00.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$8.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$8.80K derived: sum of 2 quarters · filed 2026-07-14 | $15.00K derived: sum of 3 quarters · filed 2026-07-14 | $15.00K 10-K · filed 2026-07-14 |
| 2025-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $23.80K derived: sum of 2 quarters · filed 2026-02-12 | $23.80K 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $23.80K 10-Q · filed 2025-11-14 | $23.80K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-07-14 | |||
| 2020-03-31 | $27.04K 10-K · filed 2020-08-13 | |||
| 2019-12-31 | $0.00 10-Q · filed 2020-02-04 | $0.00 derived: sum of 2 quarters · filed 2020-02-04 | $27.04K 10-Q · filed 2020-02-04 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-13 | $27.04K 10-Q · filed 2019-11-13 | ||
| 2019-03-31 | $0.00 10-K · filed 2020-08-13 | |||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-04 | $0.00 derived: sum of 2 quarters · filed 2020-02-04 | $0.00 10-Q · filed 2020-02-04 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 |